No Detail Found!

Uterocutaneous fistula managed medically: A case report.

Author(s)
Koulshan Mustafa Department of Gynecology and Obstetrics, Canadian Specialist Hospital Abu hail- Dubai- UAE,,
Gul-e-Rana Abdul Department of Gynecology and Obstetrics, Canadian Specialist Hospital Abu hail- Dubai- UAE,,
Rabiya Niaz Department of Gynecology and Obstetrics, Canadian Specialist Hospital Abu hail- Dubai- UAE,,
Durr-e-shahwar Hayat Department of Radiology, Memon medical institute hospital Karachi-,,Pakistan
Anum sultan Department of Radiology, Ziauddin medical university hospital Karachi-,,Pakistan
Abstract
Background: The uterocutaneous fistula is an abnormal connection or passageway between the uterus and the skin. The most common causes include infections, trauma, or surgery, a severe medical condition requiring prompt medical attention and treatment. Case Presentation: Here, we describe the case of a 36-year-old female who developed a uterocutaneous fistula after cesarean delivery. Her post-cesarean recovery was complicated by wound infection, and after healing the wound, she presented with cyclical bloody discharge from a pinpoint opening in the healed wound scar. Management: On ultrasound and MRI, she was diagnosed as having a uterocutaneous fistula. She opted for non-surgical management and underwent successful medical management with GnRH agonists. She remained symptom-free after the resumption of her menstrual cycle. Conclusion: In younger populations hoping to avoid surgery, pharmacological care with GnRH agonist therapy can be a reasonable alternative to surgical resection of the fistulous tract. Healthcare professionals should have a high index of suspicion to diagnose this condition.
Publication Details
Page(s) 104-109
Published Journal: International Journal of Endorsing Health Science Research, Volume: 11, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Laparotomy, Uterocutaneous Fistula, GnRH Agonists., Septic Abortion, Myomectomy
0

Citations

0

Downloads

58

Views